View in EDS PDF Full Text

Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer.

Saved in:
Bibliographic Details
Title: Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer.
Authors: Bazargan S; Department of Immunology, Moffitt Cancer Center, Tampa, FL, United States., Bunch B; Department of Immunology, Moffitt Cancer Center, Tampa, FL, United States., Ojwang' AME; Department of Integrated Mathematical Oncology, Moffitt Cancer Center, Tampa, FL, United States., Blauvelt J; Department of Immunology, Moffitt Cancer Center, Tampa, FL, United States., Landin A; Department of Immunology, Moffitt Cancer Center, Tampa, FL, United States., Ali J; Department of Immunology, Moffitt Cancer Center, Tampa, FL, United States., Abrahams D; Comparative Medicine, University of South Florida, Tampa, FL, United States., Cox C; Cell Therapy Facility, Moffitt Cancer Center, Tampa, FL, United States., Hall AM; Department of Immunology, Moffitt Cancer Center, Tampa, FL, United States., Beatty MS; Department of Immunology, Moffitt Cancer Center, Tampa, FL, United States., Poch M; Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, United States., Rejniak KA; Department of Integrated Mathematical Oncology, Moffitt Cancer Center, Tampa, FL, United States., Pilon-Thomas S; Department of Immunology, Moffitt Cancer Center, Tampa, FL, United States.; Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, United States.
Source: Frontiers in immunology [Front Immunol] 2023 Oct 12; Vol. 14, pp. 1275375. Date of Electronic Publication: 2023 Oct 12 (Print Publication: 2023).
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37901214
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Bazargan+S%22">Bazargan S</searchLink>; Department of Immunology, Moffitt Cancer Center, Tampa, FL, United States.<br /><searchLink fieldCode="AU" term="%22Bunch+B%22">Bunch B</searchLink>; Department of Immunology, Moffitt Cancer Center, Tampa, FL, United States.<br /><searchLink fieldCode="AU" term="%22Ojwang'+AME%22">Ojwang' AME</searchLink>; Department of Integrated Mathematical Oncology, Moffitt Cancer Center, Tampa, FL, United States.<br /><searchLink fieldCode="AU" term="%22Blauvelt+J%22">Blauvelt J</searchLink>; Department of Immunology, Moffitt Cancer Center, Tampa, FL, United States.<br /><searchLink fieldCode="AU" term="%22Landin+A%22">Landin A</searchLink>; Department of Immunology, Moffitt Cancer Center, Tampa, FL, United States.<br /><searchLink fieldCode="AU" term="%22Ali+J%22">Ali J</searchLink>; Department of Immunology, Moffitt Cancer Center, Tampa, FL, United States.<br /><searchLink fieldCode="AU" term="%22Abrahams+D%22">Abrahams D</searchLink>; Comparative Medicine, University of South Florida, Tampa, FL, United States.<br /><searchLink fieldCode="AU" term="%22Cox+C%22">Cox C</searchLink>; Cell Therapy Facility, Moffitt Cancer Center, Tampa, FL, United States.<br /><searchLink fieldCode="AU" term="%22Hall+AM%22">Hall AM</searchLink>; Department of Immunology, Moffitt Cancer Center, Tampa, FL, United States.<br /><searchLink fieldCode="AU" term="%22Beatty+MS%22">Beatty MS</searchLink>; Department of Immunology, Moffitt Cancer Center, Tampa, FL, United States.<br /><searchLink fieldCode="AU" term="%22Poch+M%22">Poch M</searchLink>; Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, United States.<br /><searchLink fieldCode="AU" term="%22Rejniak+KA%22">Rejniak KA</searchLink>; Department of Integrated Mathematical Oncology, Moffitt Cancer Center, Tampa, FL, United States.<br /><searchLink fieldCode="AU" term="%22Pilon-Thomas+S%22">Pilon-Thomas S</searchLink>; Department of Immunology, Moffitt Cancer Center, Tampa, FL, United States.; Department of Genitourinary Oncology, Moffitt Cancer Center, Tampa, FL, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2023 Oct 12; Vol. 14, pp. 1275375. <i>Date of Electronic Publication: </i>2023 Oct 12 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37901214
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2023.1275375
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1275375
    Titles:
      – TitleFull: Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Bazargan S
      – PersonEntity:
          Name:
            NameFull: Bunch B
      – PersonEntity:
          Name:
            NameFull: Ojwang' AME
      – PersonEntity:
          Name:
            NameFull: Blauvelt J
      – PersonEntity:
          Name:
            NameFull: Landin A
      – PersonEntity:
          Name:
            NameFull: Ali J
      – PersonEntity:
          Name:
            NameFull: Abrahams D
      – PersonEntity:
          Name:
            NameFull: Cox C
      – PersonEntity:
          Name:
            NameFull: Hall AM
      – PersonEntity:
          Name:
            NameFull: Beatty MS
      – PersonEntity:
          Name:
            NameFull: Poch M
      – PersonEntity:
          Name:
            NameFull: Rejniak KA
      – PersonEntity:
          Name:
            NameFull: Pilon-Thomas S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 10
              Text: 2023 Oct 12
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 14
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1